CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Chief Medical Officer bought 500 shares at $2.55 ($1,275)
- 4 Open-market buy Director bought 3,927,126 shares at an average $4.33 ($17,000,003)
- 4 Open-market buy CFO bought 20,000 shares at $1.69 ($33,830)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $1.88 ($18,800)
- 4/A Open-market buy Chief Medical Officer bought 500 shares at $1.85 ($925)
- 8-K Event Material agreement · Auditor change
- 4 Open-market buy Director bought 115,450 shares at an average $3.20 ($369,858)
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 500 shares at $1.85 ($925)
- 4 Open-market buy CFO bought 50,000 shares at $1.93 ($96,345)
- 4 Open-market buy CEO bought 5,000 shares at $1.68 ($8,400)
- 4 Open-market buy Chief Medical Officer bought 8,000 shares at an average $1.69 ($13,540)
- 8-K Event Other events
- 4 Open-market buy Chief Medical Officer bought 7,000 shares at $1.31 ($9,142)
- 4 Open-market buy CFO bought 50,900 shares at an average $1.31 ($66,741)
Page 9 of 38 · 760 filings